Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 13.61 Million USD | 9782.4% |
| 2022 | 137.76 Thousand USD | -89.95% |
| 2021 | 1.37 Million USD | -37.02% |
| 2020 | 2.17 Million USD | 52.07% |
| 2019 | 1.43 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | -3.38 Million USD | -2554.96% |
| 2023 FY | 13.61 Million USD | 9782.4% |
| 2023 Q4 | 13.61 Million USD | 267.41% |
| 2023 Q3 | 3.7 Million USD | 641.5% |
| 2023 Q2 | -684.31 Thousand USD | 79.77% |
| 2022 Q3 | -2.24 Million USD | -205.53% |
| 2022 Q4 | 137.76 Thousand USD | 106.13% |
| 2022 FY | 137.76 Thousand USD | -89.95% |
| 2022 Q1 | 2.46 Million USD | 79.47% |
| 2022 Q2 | 2.12 Million USD | -13.54% |
| 2021 Q1 | 3076.00 USD | -99.85% |
| 2021 FY | 1.37 Million USD | -37.02% |
| 2021 Q4 | 1.37 Million USD | -45.34% |
| 2021 Q3 | 2.5 Million USD | 0.0% |
| 2020 FY | 2.17 Million USD | 52.07% |
| 2020 Q4 | 2.07 Million USD | 0.0% |
| 2019 FY | 1.43 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | -639.236% |
| Alpha Teknova, Inc. | 1.97 Million USD | -589.7% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 85.548% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 81.835% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 96.873% |
| Cosmos Health Inc. | 8.59 Million USD | -58.481% |
| Journey Medical Corporation | -9.7 Million USD | 240.227% |
| Embecta Corp. | 1.31 Billion USD | 98.962% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 97.032% |
| Dynavax Technologies Corporation | 106.63 Million USD | 87.232% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 110.406% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 96.854% |
| PainReform Ltd. | -7.95 Million USD | 271.254% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 187.08% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 187.08% |
| SCYNEXIS, Inc. | -19.35 Million USD | 170.36% |
| Safety Shot Inc | -2.28 Million USD | 695.991% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 244.38% |
| Procaps Group, S.A. | 242.93 Million USD | 94.396% |
| Theratechnologies Inc. | 24.87 Million USD | 45.259% |
| Harrow Health, Inc. | 116.41 Million USD | 88.305% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 640.265% |
| Biofrontera Inc. | 4.05 Million USD | -235.668% |
| DURECT Corporation | -7.65 Million USD | 277.877% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 140.608% |
| Cronos Group Inc. | -663.32 Million USD | 102.052% |
| OptiNose, Inc. | 58.06 Million USD | 76.553% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 97.816% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 193.43% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 362.526% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 9.314% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 314.079% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -12640.789% |
| Radius Health, Inc. | 359.28 Million USD | 96.211% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -6803.681% |
| ProPhase Labs, Inc. | 19.23 Million USD | 29.205% |
| Phibro Animal Health Corporation | 454.84 Million USD | 97.007% |
| Procaps Group S.A. | 242.93 Million USD | 94.396% |
| Alvotech | 1.06 Billion USD | 98.721% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -270.165% |
| Viatris Inc. | 17.13 Billion USD | 99.921% |
| Rockwell Medical, Inc. | 4.45 Million USD | -205.536% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 379.161% |
| SIGA Technologies, Inc. | -148.68 Million USD | 109.157% |
| Tilray Brands, Inc. | 158.97 Million USD | 91.436% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 88.831% |
| Shineco, Inc. | 29.29 Million USD | 53.518% |
| PetIQ, Inc. | 351.93 Million USD | 96.131% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 569.241% |
| Incannex Healthcare Limited | -5.48 Million USD | 348.217% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 92.321% |
| Alimera Sciences, Inc. | 55.3 Million USD | 75.384% |
| Silver Spike Investment Corp. | -32.61 Million USD | 141.748% |
| Assertio Holdings, Inc. | -32.52 Million USD | 141.854% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 1014.521% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 369.044% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 382.814% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 265.76% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -222.852% |
| Talphera, Inc. | -5.72 Million USD | 337.977% |
| Alvotech | 1.06 Billion USD | 98.721% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | -90.548% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 114.078% |
| Currenc Group, Inc. | -16.57 Million USD | 182.149% |
| Kamada Ltd. | -46.43 Million USD | 129.322% |
| Indivior PLC | -33.95 Million USD | 140.1% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -5124.88% |
| Flora Growth Corp. | -713 Thousand USD | 2009.492% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 265.76% |
| Evolus, Inc. | 63.7 Million USD | 78.63% |
| HUTCHMED (China) Limited | -197.45 Million USD | 106.895% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 97.158% |
| Akanda Corp. | 3.9 Million USD | -248.655% |